» Articles » PMID: 37138561

Joint Statement for Assessing and Managing High Blood Pressure in Children and Adolescents: Chapter 1. How to Correctly Measure Blood Pressure in Children and Adolescents

Abstract

The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.

Citing Articles

Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension.

Park S, An H, Kim S, Kim S, Cho H, Kim J Kidney Res Clin Pract. 2025; 44(1):20-48.

PMID: 39923806 PMC: 11864819. DOI: 10.23876/j.krcp.24.096.


Challenges in blood pressure measurement in children with obesity: focus on the cuff.

Evripidou K, Chainoglou A, Kotsis V, Stabouli S Pediatr Nephrol. 2025; .

PMID: 39907759 DOI: 10.1007/s00467-025-06678-5.


Understanding the Impact of Obesity and Parental Blood Pressure in Identifying Optimal Hypertension Screening Group in Youth.

Koncar D, Kovacevic A, Miler M, Sabolic L, Dika Z, Softic D Cureus. 2024; 16(11):e74550.

PMID: 39669841 PMC: 11635545. DOI: 10.7759/cureus.74550.


Association of serum transforming growth factor β with left ventricular hypertrophy in children with primary hypertension.

Liu Y, Lin Y, Huang X, Li Y, Liu Y, Shi L Eur J Pediatr. 2023; 182(12):5439-5446.

PMID: 37755472 PMC: 10746758. DOI: 10.1007/s00431-023-05219-2.

References
1.
Starr M, Flynn J . Neonatal hypertension: cases, causes, and clinical approach. Pediatr Nephrol. 2018; 34(5):787-799. PMC: 6261698. DOI: 10.1007/s00467-018-3977-4. View

2.
Lurbe E, Redon J, Alvarez J, Grau-Perez M, Martinez F, Mancia G . Insights From Matched Office and Ambulatory Blood Pressure in Youth: Clinical Relevance. Hypertension. 2022; 79(6):1237-1246. DOI: 10.1161/HYPERTENSIONAHA.122.18993. View

3.
Redon J, Lurbe E . Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: con side of the argument. Hypertension. 2014; 64(6):1169-74. DOI: 10.1161/HYPERTENSIONAHA.114.03883. View

4.
Neuhauser H, Thamm M, Ellert U, Hense H, Schaffrath Rosario A . Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics. 2011; 127(4):e978-88. DOI: 10.1542/peds.2010-1290. View

5.
Stergiou G, Stambolliu E, Bountzona I, Ntineri A, Kollias A, Vazeou A . Home Blood Pressure Monitoring in Children and Adolescents: Systematic Review of Evidence on Clinical Utility. Curr Hypertens Rep. 2019; 21(8):64. DOI: 10.1007/s11906-019-0967-2. View